DeepMed Research

THE COOPER HEALTH SYSTEM

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Stereotactic Radiosurgery for Soft Tissue Sarcoma

Not Applicable

Withdrawn

Conditions: Soft Tissue Sarcoma

Interventions: Radiation: CyberKnife

First Posted Date: 2016-03-11

Last Posted Date: 2024-03-15

Lead Sponsor: The Cooper Health System

Registration Number: NCT02706171

Locations: 🇺🇸
MD Anderson Cancer Center at Cooper, Camden, New Jersey, United States

Reoxygenation After Cardiac Arrest II (REOX II Study)

Phase 1

Completed

Conditions: Cardiac Arrest

Interventions: Other: Protocol for rapid FiO2 optimization

First Posted Date: 2016-03-04

Last Posted Date: 2022-03-29

Lead Sponsor: The Cooper Health System

Target Recruit Count: 16

Registration Number: NCT02698826

Locations: 🇺🇸
Indiana University/ Methodist Hospital, Indianapolis, Indiana, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States

and more 2 locations

Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

Phase 3

Completed

Conditions: Post-ERCP Acute Pancreatitis

Interventions: Drug: Normal Saline
Drug: Lactated Ringer's Solution
Drug: Indomethacin
Drug: Placebo

First Posted Date: 2015-12-29

Last Posted Date: 2018-02-27

Lead Sponsor: The Cooper Health System

Target Recruit Count: 192

Registration Number: NCT02641561

Locations: 🇺🇸
Cooper Hospital, Camden, New Jersey, United States

Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung Cancer

Early Phase 1

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Pemetrexed
Drug: Carboplatin
Drug: Cisplatin
Drug: Docetaxel
Drug: Paclitaxel
Radiation: stereotactic radiosurgery

First Posted Date: 2015-10-05

Last Posted Date: 2017-01-31

Lead Sponsor: The Cooper Health System

Target Recruit Count: 22

Registration Number: NCT02568033

Locations: 🇺🇸
MD Anderson Cancer Center at Cooper, Camden, New Jersey, United States

Stereotactic Radiosurgery (SRS) for Multiple CNS Mets

Not Applicable

Withdrawn

Conditions: Metastatic Cancer
Brain Metastases

Interventions: Radiation: Stereotactic Radiosurgery

First Posted Date: 2015-10-05

Last Posted Date: 2022-01-11

Lead Sponsor: The Cooper Health System

Registration Number: NCT02567643

Locations: 🇺🇸
MD Anderson Cancer Center at Cooper, Camden, New Jersey, United States

Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression

Not Applicable

Terminated

Conditions: Depression, Postpartum

Interventions: Drug: Placebo
Drug: Sertraline

First Posted Date: 2014-09-09

Last Posted Date: 2018-03-29

Lead Sponsor: The Cooper Health System

Target Recruit Count: 2

Registration Number: NCT02235064

Locations: 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States

Clobazam Use in Epilepsia Partialis Continua - Pilot Study

Phase 3

Terminated

Conditions: Epilepsia Partialis Continua
Kojewnikov's Epilepsy
Epilepsy

Interventions: Drug: Clobazam
Drug: Clonazepam
Drug: Lorazepam

First Posted Date: 2014-05-09

Last Posted Date: 2018-05-09

Lead Sponsor: The Cooper Health System

Target Recruit Count: 7

Registration Number: NCT02134366

Locations: 🇺🇸
Cooper Universtiy Hospital, Camden, New Jersey, United States

Study of Defibrillation Testing In Patients Undergoing Initial ICD Implantation

Phase 4

Conditions: Ventricular Arrhythmias

Interventions: Device: Defibrillation testing

First Posted Date: 2013-07-22

Last Posted Date: 2013-07-22

Lead Sponsor: The Cooper Health System

Target Recruit Count: 100

Registration Number: NCT01905007

Locations: 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States
🇺🇸
University of Washington, Seattle, Washington, United States

Reoxygenation After Cardiac Arrest (REOX Study)

Completed

Conditions: Cardiac Arrest

First Posted Date: 2013-06-19

Last Posted Date: 2019-11-25

Lead Sponsor: The Cooper Health System

Target Recruit Count: 280

Registration Number: NCT01881243

Locations: 🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Cooper University Hospital, Camden, New Jersey, United States

and more 2 locations

Bisacodyl Use in the Post-operative Care of Obstetrical/Gynecological (OB/GYN) Patients

Phase 2

Completed

Conditions: Postoperative Nausea and Vomiting
Abdominal Pain

Interventions: Drug: Bisacodyl
Drug: placebo

First Posted Date: 2009-11-11

Last Posted Date: 2014-01-20

Lead Sponsor: The Cooper Health System

Target Recruit Count: 285

Registration Number: NCT01011426

Locations: 🇺🇸
Cooper University Hospital, Camden, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy